Medical Device and Diagnostic Industry (MD+DI)

Dexcom Faces G6 Recall

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...
Investing

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential

Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...

"It’s life-threatening"—Dexcom G7 users say glucose monitor is failing them

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
CNET

Best Continuous Glucose Monitors, According to Experts

Nasha is a Managing Editor for CNET, overseeing our sleep and wellness verticals. She is a nutrition, mental health, fitness and sleep science enthusiast. Her passion for mindful and holistic ...
Investing

Stifel resumes DexCom stock coverage with Buy rating on 15-day sensor potential

Investing.com - Stifel resumed coverage of DexCom (NASDAQ:DXCM) with a Buy rating and set a price target of $85.00, according to a research note published Monday. The company, currently trading at $68 ...
mayo

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...